Rare Tumours of Male Genital Organs
|
|
|
- Barnard Austin
- 5 years ago
- Views:
Transcription
1 Rare Tumours of Male Genital Organs 1. Epithelial Tumours of Prostate 1.1 General Results Table 1. Epithelial Tumours of Prostate: Incidence, Trends, Survival Flemish Region Incidence Trend Survival Males EAPC Relative survival R/C N CR WSR Avg Age % p-value N at risk 5yr (%) EPITHELIAL TUMOURS OF PROSTATE C 56, , Adenocarcinoma with variants of prostate C 56, , Squamous cell carcinoma with variants of prostate R * * 10 * Infiltrating duct carcinoma of prostate R Transitional cell carcinoma of prostate R * * 14 * Salivary gland type tumours of prostate R R/C: Rare or common CR: Crude rate (N/100,000 person years) WSR: age-standardised rate, using the world population (N/100,000 person years) EAPC: estimated annual percentage change RS: relative survival AvgAge: average age at diagnosis 1.2 Incidence 56,753 new epithelial tumours of the prostate are diagnosed in the Flemish Region between 2001 and RARECARE defines one common and four rare entities: o 99% of prostate carcinoma are common adenocarcinoma. o Squamous cell carcinoma in the Flemish Region represent only 12 cases. o Infiltrating duct carcinoma is the most frequently occurring rare entity with 188 new diagnoses. o Only 17 cases of transitional prostate carcinoma are observed. o Salivary gland type tumours account for 131 new diagnoses. Figure 1. Rare Epithelial Tumours of Prostate: Age Specific Incidence 1
2 Prostate tumours only rarely occur in patients younger than 50 years of age. From the age of 50 years, age specific incidence rates increase. 1.3 Survival Overall Survival Table 2. Epithelial Tumours of Prostate - Overall Survival N Observed Survival Relative Survival at risk 1 year 3 year 5 year 10 year 5 year CI 1 year 3 year 5 year 10 year 5 year CI EPITELIAL TUMOURS OF PROSTATE 52, [77.3 ; 78.1] [94.5 ; 95.4] Adenocarcinoma with variants 52, [77.7 ; 78.5] [91.2 ; 93.4] Squamous cell carcinoma with variants 10 * * * * * * * * * * Infiltrating duct carcinoma [57.8 ; 73.0] [71.3 ; 90.1] Transitional cell carcinoma 14 * * * * * * * * * * Salivary gland type tumours [78.0 ; 91.8] [91.9 ; 108.1] * No survival results are shown because the number at risk is lower than 35. Overall survival of prostate tumours is good, with a relative 10 year survival of 91.9%. This is remarkably worse in infiltrating duct carcinoma Survival by Age Group 1 Figure 2. Epithelial Tumours of Prostate - Relative Survival by Age Group Epithelial tumours of the prostate have a very good prognosis. The 5-year relative survival is somewhat worse for the 75+ age group although it reaches almost 90%. 1 Survival by age group is not displayed for salivary glands type tumours of prostate because only stage II has a number at risk higher than 35. 2
3 Figure 3. Adenocarcinoma with Variants, Infiltrating Duct Carcinoma of Prostate - Relative Survival by Age Group * Survival of patients aged in the age group 0-59 is not shown because the number at risk is lower than 35 The poorer survival for infiltrating duct carcinoma of the prostate compared with the other histology groups is observed in all different age groups Survival by Stage Figure 4. Epithelial Tumours of Prostate - Relative Survival by Stage All stages, except stage IV, have a good prognosis. 3
4 Figure 5. Adenocarcinoma with Variants, Infiltrating Duct Carcinoma and Salivary Gland Type Tumours of Prostate - Relative Survival by Stage * Survival of stage I, IV is not shown because the number at risk is lower than 35. ** Survival of stage I, III and IV is not shown because the number at risk is lower than Tumours of Testis and Paratestis 2.1 General Results Table 3. Tumours of Testis and Paratestis: Incidence, Trends, Survival Flemish Region Males Incidence Trend EAPC Survival Relative survival R/C N CR WSR Avg Age % p-value N at risk 5yr (%) TUMOURS OF TESTIS AND PARATESTIS R 1, , Adenocarcinoma with variants of paratestis R * * 3 * Germ cell non seminomatous tumours of testis R < Germ cell seminomatous tumours of testis R Spermatocytic seminoma R * * 16 * Teratoma with malignant transformation R Sex cord tumours of testis R * * 21 * R/C: Rare or common CR: Crude rate (N/100,000 person years) WSR: age-standardised rate, using the world population (N/100,000 person years) EAPC: estimated annual percentage change RS: relative survival AvgAge: average age at diagnosis 4
5 2.2 Incidence 1,503 new epithelial tumours of the testis and paratestis are diagnosed in the Flemish Region between 2001 and RARECARE defines six rare entities: o Only three adenocarcinoma with variants of paratestis are registered. o Germ cell tumours represent 95% of testicular tumours; slightly more seminomatous than non seminomatous germ cell tumours are registered. o Spermatocytic seminoma accounts for 16 new diagnoses. o No teratoma with malignant transformation is observed in the Flemish Region between 2001 and o 26 cases are sex cord testicular tumours. Figure 6. Tumours of Testis and Paratestis: Age Specific Incidence by Histology Non-seminomatous tumours show an incidence peak between 20 and 25 years, seminomatous germ cell tumours show a similar age specific curve, with a ten year delay. Figure 7. Tumours of Testis and Paratestis: Stage Distribution by Histology* * Stage IV does not exists in the staging of testicular cancer. Information on stage is missing in about 10-15% of the cases. Pathological staging is more frequently available than clinical staging. 5
6 Clinical staging reveals more stage II and III tumours than pathological staging. Non-seminomatous germ cell tumours have a slightly less favourable prognostic stage distribution than seminomatous germ cell tumours. 2.3 Trends Figure 8. Seminomatous and Non-Seminomatous Germ Cell Tumours of Testis: Age-Standardised Incidence There is an increase of the incidence in the age group years for both subtypes although more pronounced for non-seminomatous tumors. For non-seminomatour tumours, the youngest age group also shows an increasing incidence but less obvious than the age group years. 2.4 Survival Overall Survival Table 4. Tumours of Testis and Paratestis - Overall Survival N Observed Survival Relative Survival at risk 1 year 3 year 5 year 10 year 5 year CI 1 year 3 year 5 year 10 year 5 year CI TUMOURS OF TESTIS AND PARATESTIS 1, [93.9 ; 96.3] [95.0 ; 97.4] Adenocarcinoma with variants of paratestis 3 * * * * * * * * * * Germ cell non seminomatous tumours of testis [95.3 ; 93.3] [93.8 ; 97.4] Germ cell seminomatous tumours of testis [94.3 ; 97.4] [95.5 ; 98.6] Spermatocytic seminoma 16 * * * * * * * * * * Teratoma with malignant transformation Sex cord tumours of testis 21 * * * * * * * * * * Testicular cancers have a very good prognosis, with a 5-year relative survival of 95.9% for germ cell non-seminomatous tumours and 97.4% for germ cell seminomatous tumours. 6
7 2.4.2 Survival by Age Group Figure 9. Tumours of Testis and Paratestis - Relative Survival by Age Group The prognosis of testicular and paratesticular cancer is very good, with an almost 100% relative 5-year survival in the age group of 0-29 years. In patients of 40 years and older, the prognosis is still very good although not as good as in the youngest population groups. Figure 10. Germ Cell Seminomatous and Non-Seminomatous Tumours of Testis - Relative Survival by Age and Histology Seminomatous tumours have the best prognosis with a relative 5-year survival of almost 100%. For non-seminomatous germ cell cancers, especially the patients of 40 years and older have a less optimal outcome. 7
8 2.4.3 Survival by Stage Figure 11. Tumours of Testis and Paratestis - Relative Survival by Stage Prognosis is very good for stage I, II and X disease but worse for stage III disease, with a less than 75% 5-year relative survival rate. Figure 12. Germ Cell Seminomatous and Non-Seminomatous Tumours of Testis - Relative Survival by Stage * Survival of stage III is not shown because the number at risk is lower than 35. Prognosis is very good in seminomatous tumours for which almost no stage III diseases are registered (n=26). There is a larger proportion of stage III diseases in the non-seminomatous group (n=80), with a worse prognosis. Prognosis of stage I and II is comparable between the two different histological groups. 8
9 3. Epithelial Tumours of Penis 3.1 General Results Table 5. Epithelial Tumours of Penis: Incidence, Trends, Survival Flemish Region Incidence Trend Survival Males EAPC Relative survival R/C N CR WSR Avg Age % p-value N at risk 5yr (%) EPITHELIAL TUMOURS OF PENIS R Squamous cell carcinoma with variants of penis R Adenocarcinoma with variants of penis R * * 3 * R/C: Rare or common CR: Crude rate (N/100,000 person years) WSR: age-standardised rate, using the world population (N/100,000 person years) EAPC: estimated annual percentage change RS: relative survival AvgAge: average age at diagnosis 3.2 Incidence 406 new epithelial penile tumours are diagnosed in the Flemish Region between 2001 and RARECARE defines two rare entities: o The majority are squamous cell carcinoma. o Only 5 adenocarcinoma are observed. Figure 13. Squamous Cell Carcinoma with Variants of Penis: Age Specific Incidence From the age of 45 years, age specific incidence rates increase rapidly. 9
10 3.3 Trends Figure 14. Squamous Cell Carcinoma of Penis: Age-Standardised Incidence As it is impossible to define the skin of penis separately, penal skin-tumours are included. The observed increase in squamous cell carcinoma of the penis is therefore possibly linked to the known increase in non-melanoma skin cancer. 3.4 Survival Overall Survival Table 6. Epithelial Tumours of Penis - Overall Survival N Observed Survival Relative Survival at risk 1 year 3 year 5 year 10 year 5 year CI 1 year 3 year 5 year 10 year 5 year CI EPITHELIAL TUMOURS OF PENIS [50.6 ; 61.9] [62.6 ; 76.5] Squamous cell carcinoma with variants [51.2 ; 62.5] [63.4 ; 77.4] Adenocarcinoma with variants 3 * * * * * * * * * * Penile cancers have a moderate prognosis with a relative 5-year survival of almost 70% Survival by Age Group Figure 15. Epithelial Tumours of Penis - Relative Survival by Age Group 10
11 Prognosis is poorer for older patients ( 75 years and older) than for younger patients. Figure 16. Squamous Cell Carcinoma with Variants of Penis - Relative Survival by Age Group Because almost all patients with an epithelial tumour of the penis are diagnosed with a squamous cell carcinoma, survival by age group is very similar for the squamous cell carcinoma as for all epithelial tumours of the penis together Survival by Stage Figure 17. Epithelial Tumours of Penis - Relative Survival by Stage * Survival of stage IV is not shown because the number at risk is lower than 35. Prognosis is worse in more advanced stage, with a 5-year relative survival in stage III disease of less than 50%. There is a comparable prognosis between stage I and II disease. 11
12 Figure 18. Squamous Cell Carcinoma with Variants of Penis - Relative Survival by Stage * Survival of stage IV is not shown because the number at risk is lower than 35. Because almost all patients with an epithelial tumour of the penis are diagnosed with a squamous cell carcinoma, survival by stage is very similar for squamous cell carcinoma as for all epithelial tumours of the penis together. 12
Rare Neuroendocrine Tumours and Cancers of Endocrine Organs
Rare Neuroendocrine Tumours and Cancers of Endocrine Organs 1. Neuroendocrine Tumours 1.1 General Results Table 1. Neuroendocrine Tumours: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes
Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence
Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival
incidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates
2 1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates Table 1: Testicular Cancer: Average age at diagnosis, number of new cancer diagnoses (N), crude rate (CR), age-standardised incidence
1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates
2 1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates Table 1: Testicular Cancer: Average age at diagnosis, number of new cancer diagnoses (N), crude rate (CR), age-standardised incidence
1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates
2 1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates Table 1: Malignant Melanoma: Average age at diagnosis, number of new cancer diagnoses (N), crude rate (CR), age-standardised incidence
1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates
2 1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates Table 1: Colorectal Cancer: Average age at diagnosis, number of new cancer diagnoses (N), crude rate (CR), age-standardised incidence
FINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as
1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates
2 1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates Table 1: Bladder Cancer: Average age at diagnosis, number of new cancer diagnoses (N), crude rate (CR), age-standardised incidence
1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates
2 1. Cancer Incidence 1.1. Number of new diagnoses and incidence rates Table 1: Colorectal Cancer: Average age at diagnosis, number of new cancer diagnoses (N), crude rate (CR), age-standardised incidence
Note: The cause of testicular neoplasms remains unknown
- In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.
Pelvic tumor in childhood Classification, imaging approach and radiological findings
Pelvic tumor in childhood Classification, imaging approach and radiological findings M. Mearadji International Foundation for Pediatric Imaging Aid Rotterdam, The Netherlands Solid pelvic masses in childhood
ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31
R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000,
-The cause of testicular neoplasms remains unknown
- In the 15- to 34-year-old age group, they are the most common tumors of men. - include: I. Germ cell tumors : (95%); all are malignant. II. Sex cord-stromal tumors: from Sertoli or Leydig cells; usually
DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #
DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #2006-01 CATEGORY: CLARIFICATION SUBJECT: RESCINDMENT - DSQC MEMORANDUM 2002-08 Coding Complex Morphologic Diagnoses (revised 8/02) EFFECTIVE: For Cases
Diseases of the penis & testis
Diseases of the penis & testis Done by : Saef B AL-Abbadi Diseases of penis, Condyloma Acuminatum A benign tumor *Tend to recur but only rarely progress into in situ or invasive cancers read this = genital
Triple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
Trends in Cancer Survival in Scotland
Scottish Cancer Intelligence Unit Trends in Cancer Survival in Scotland - Trends in survival are presented for the half million adult cancer patients diagnosed in Scotland between and. The Results show,
SUPPLEMENTARY INFORMATION
Supplementary Table 1 trials currently open for patients with pheochromocytoma and/or paraganglima (from trials.gov) www.clinicaltrials.gov; Active PPGL trials Status Of Sunitinib In Patients With Recurrent
Cardiff MRCS OSCE Courses Testicular Cancer
Testicular Cancer Scenario: A 40-year-old male presents to the surgical out-patient clinic with a 6-8 week history of a painless lump in his left scrotum. He however complains of a dull ache in the scrotum
UK CAA Oncology Certification Charts
UK CAA Oncology Certification Charts 1. Colorectal 2. Malignant Melanoma 3. Germ Cell Tumour of Testis 4. Renal Cell Carcinoma 5. Breast Carcinoma 6. Non-small Cell Lung Cancer Note: All Class 1 cases
Study Into The Patterns of Male Genital Tract Tumors
ORIGINAL ARTICLE Study Into The Patterns of Male Genital Tract Tumors Archana Gupta, Sunil Gupta, Yudhvir Gupta Abstract Pattern of a particular disease in any population is studied with the idea of getting
Testicular Germ Cell Tumors; A Simplistic Approach
Testicular Germ Cell Tumors; A Simplistic Approach Merce Jorda, MD, PhD, MBA Professor and Vice Chair, Director of Anatomic Pathology Director of Genitourinary Pathology Service Interim Director of Cytopathology
came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary
Thorax 1982;37:366-370 Thoracic metastases MARY P SHEPHERD From the Thoracic Surgical Unit, Harefield Hospital, Harefield ABSTRACI One hundred and four patients are reviewed who were found to have thoracic
Treatment Testicular Cancer Guidelines
Treatment Testicular Cancer Guidelines Thank you very much for reading. As you may know, people have look hundreds times for their chosen readings like this, but end up in infectious downloads. Rather
Uropathology January Jon Oxley
Uropathology January 2012 Jon Oxley Background to seminar These slides were available to view via the web from scanned slides The junior pathologists answered questions on them via the web The answers
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
In the third part of the present study tumours which previous were described as basal cell tumours but now have been reclassified as trichoblastomas
170 6. SUMMARY Immunhistochemical investigations for identifying the histogenesis of basaloid neoplasias and hyperplasias in the mamma parenchyma of the bitch, for the use of the human nuclear protein
DISORDERS OF MALE GENITALS
Wit JM, Ranke MB, Kelnar CJH (eds): ESPE classification of paediatric endocrine diagnosis. 9. Testicular disorders/disorders of male genitals. Horm Res 2007;68(suppl 2):63 66 ESPE Code Diagnosis OMIM ICD10
CODING TUMOUR MORPHOLOGY. Otto Visser
CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show
Protocol for the Examination of Lymphadenectomy Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis
Protocol for the Examination of Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis Version: Testis 4.0.1.1 Protocol Posting Date: February 2019 Accreditation Requirements
Vascular Related Torsion Venous compression Hemorrhagic infarct Young men At night Very painful Can be reduced Scrotal Masses Testicular Tumors (solid
Pathology of the Male Reproductive System Testis and Epididymis Failure of Testis to Descend Testis are not always in scrotum at birth. Testes from in abdomen with kidneys Migrate to scrotum May get stuck
FINALIZED SEER SINQ QUESTIONS April July, 2017
20170040 Source 1: 2016 SEER Manual pgs: 91 Source 2: 2007 MP/H Rules Notes: Lung MP/H Rules/Histology--Lung: What is the histology code for lung cancer case identified pathologically from a metastatic
Prof. Dr. med. Beata BODE-LESNIEWSKA Institute of Pathology and Molecular Pathology University Hospital; Zurich
Prof. Dr. med. Beata BODE-LESNIEWSKA Institute of Pathology and Molecular Pathology University Hospital; Zurich 32 year old man 2 months history of growing left supraclavicular lymph nodes Antibiotic treatment
Histological Typing Of Cancer And Precancer Of The Oral Mucosa
Histological Typing Of Cancer And Precancer Of The Oral Mucosa 1 / 7 2 / 7 3 / 7 Histological Typing Of Cancer And Within the last decade, histologic grading has become widely accepted as a powerful indicator
Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency
Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency World Health Organization Available in Feb 2016 Frame work for reporting Major contributing
Trends in cancer incidence in South East England Henrik Møller and all staff at the Thames Cancer Registry, King s College London
Trends in cancer incidence in South East England 1960-2009 Henrik Møller and all staff at the Thames Cancer Registry, King s College London 1 2 3 Analysts Vicki Coupland Ruth Jack Margreet Lüchtenborg
Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017
Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Dr Puay Hoon Tan Division of Pathology Singapore General Hospital Prostate cancer (acinar adenocarcinoma) Invasive carcinoma composed
Rare Urological Cancers Urological Cancers SSCRG
Rare Urological Cancers Urological Cancers SSCRG Public Health England South West Knowledge & Intelligence Team 1 Introduction Rare urological cancers are defined here as cancer of the penis, testes, ureter
Cancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
Comparative Analysis of Stage and Other Prognostic Factors Among Urethral, Ureteral, and Renal Pelvis Malignant Tumors
Comparative Analysis of Stage and Other Prognostic Factors Among Urethral, Ureteral, and Renal Pelvis Malignant Tumors Presented to NAACCR Annual Conference 2012 Serban Negoita, MD, DrPH; Marsha Dunn,
Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013
bs_bs_banner doi:10.1111/jog.12360 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 338 348, February 2014 Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 Daisuke
RARECARENet country report Bulgaria
RARECARENet country report Bulgaria 26 April 2016 Contents 1. Introduction... 3 2. The epidemiology of rare cancers in Bulgaria... 4 3. Quality indicators for centres of expertise for rare cancers... 5
Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1
MPH s 11/8/07 Other s 1 Table 2 Continued Use this two-page table to select combination histology codes. Compare the terms in the diagnosis to the terms in Columns 1 and 2. If the terms match, code the
Inamoto, Teruo; Azuma, Haruhito; Iw Sakamoto, Takeshi; Katsuoka, Yoji. Citation 泌尿器科紀要 (2005), 51(9):
Title A rare case of penile metastasis of with priapism Author(s) Inamoto, Teruo; Azuma, Haruhito; Iw Sakamoto, Takeshi; Katsuoka, Yoji Citation 泌尿器科紀要 (2005), 51(9): 639-642 Issue Date 2005-09 URL http://hdl.handle.net/2433/113675
Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
bs_bs_banner doi:10.1111/jog.12596 J. Obstet. Gynaecol. Res. Vol. 41, No. 2: 167 177, February 2015 Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
Institute of Pathology First Faculty of Medicine Charles University. Ovary
Ovary Barrett esophagus ph in vagina between 3.8 and 4.5 ph of stomach varies from 1-2 (hydrochloric acid) up to 4-5 BE probably results from upward migration of columnar cells from gastroesophageal junction
Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
Urology An introduction to cut up DR J R GOEPEL
Urology An introduction to cut up DR J R GOEPEL Overview Principles Individual organs Small pieces Partial resections Whole organs Data recording and data sets Principles You are working for the patient
APPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
Survival in Teenagers and Young. Adults with Cancer in the UK
Survival in Teenagers and Young Adults with Cancer in the UK Survival in Teenagers and Young Adults (TYA) with Cancer in the UK A comparative report comparing TYA cancer survival with that of children
ONCOLOGY. Csaba Bödör. Department of Pathology and Experimental Cancer Research november 19., ÁOK, III.
ONCOLOGY Csaba Bödör Department of Pathology and Experimental Cancer Research 2018. november 19., ÁOK, III. bodor.csaba1@med.semmelweis-univ.hu ONCOLOGY Characteristics of Benign and Malignant Neoplasms
HISTOPATHOLOGICAL STUDY OF TESTICULAR TUMORS IN NORTH-WEST RAJASTHAN (BIKANER REGION)
HISTOPATHOLOGICAL STUDY OF TESTICULAR TUMORS IN NORTH-WEST RAJASTHAN (BIKANER REGION) *Rankawat Madhu Sudan, Vyas S.P. and Swami Sarika Department of Pathology, Sardar Patel Medical College, Bikaner *Author
RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI EPITHELIAL TUMOURS OF CERVIX UTERI
RARE TUMOURS OF THE FEMALE GENITAL SYSTEM 17% OF FEMALE GENITAL SYSTEM TUMOURS ARE RARE 3 093 553 RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI 6 7 % OF RARE TUMOURS OUT OF
AETIOLOGY OF LUNG CANCER
43 THE SIGNIFICANCE OF CELL TYPE IN RELATION TO THE AETIOLOGY OF LUNG CANCER R. DOLL, A. BRADFORD HILL D L. KREYBERG From the Statistical Research Unit of the Medical Research Council, London School of
Chemotherapy Treatment Algorithms for Urology Cancer
Chemotherapy Treatment Algorithms for Urology Cancer Chemoradiation for bladder cancer; Chemotherapy algorithm for non TCC bladder cancer Squamous cell carcinoma; Chemotherapy Algorithm for Non Transitional
Using Cancer Registry Data for Post Marketing Surveillance of Rare Cancers
Using Cancer Registry Data for Post Marketing Surveillance of Rare Cancers Hannah K Weir, PhD Epidemiology and Applied Research Branch Division of Cancer Prevention and Control CDC NAACCR Annual Conference
Histomorphological spectrum of tumor and tumor like lesions of testis and paratesticular structures A cross sectional study
Original Research Article DOI: 10.5958/2394-6792.2016.00098.3 Histomorphological spectrum of tumor and tumor like lesions of testis and paratesticular structures A cross sectional study Sanjay M 1,*, Sushma
STAGING AND FOLLOW-UP STRATEGIES
ATHENS 4-6 October 2018 European Society of Urogenital Radiology STAGING AND FOLLOW-UP STRATEGIES Ahmet Tuncay Turgut, MD Professor of Radiology Hacettepe University, Faculty of Medicine Ankara 2nd ESUR
Atlas of Male Reproductive Pathology
Atlas of Male Reproductive Pathology Current Histopathology Consultant Editor Professor G. Austin Gresham, TO, SeD, MO, FRC Path. Professor of Morbid Anatomy and Histology, University of Cambridge Volume
Information Services Division NHS National Services Scotland
Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland
Ultrasound of malignant testicular lesions. Arne Hørlyck Department of Radiology Aarhus University Hospital, Skejby
Ultrasound of malignant testicular lesions Arne Hørlyck Department of Radiology Aarhus University Hospital, Skejby Testis Ultrasound is fantastic!! Scrotum Extratesticular mass: Benign Intratesticular
Information Services Division NHS National Services Scotland
Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland
Doppler ultrasound of the abdomen and pelvis, and color Doppler
- - - - - - - - - - - - - Testicular tumors are rare in children. They account for only 1% of all pediatric solid tumors and 3% of all testicular tumors [1,2]. The annual incidence of testicular tumors
Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.
Tumour Markers What are Tumour Markers? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer
Clinicopathological and Histological Features of Ovarian Tumour- A Study
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 9 Ver. IX (September. 2017), PP 56-60 www.iosrjournals.org Clinicopathological and Histological
Leukaemia 35% Lymphoma 14%
Distribution ib ti of Cancers in Children under 15 years Leukaemia 35% Lymphoma 14% Neuroblastoma 9% Other 5% Liver 1% Retinoblastoma 3% Bone and STS 15% CNS 20% Wilms' 8% 30-40% Mortality Germ Cell Tumours
Review of the AP Part II Practical Examination. Dr David Clift Co Chief Examiner
Review of the AP Part II Practical Examination Dr David Clift Co Chief Examiner General Remarks The part II practical examination involved 15 cases which were presented with sufficient clinical data to
UICC TNM 8 th Edition Errata
UICC TNM 8 th Edition Errata ions are in italics Page 28 Oropharynx p16 positive Pathological Stage II,T2 N2 M0 T3 N0,N1 M0 Stage II,T2 N2 M0 T3,T4 N0,N1 M0 Page 61 Oesophagus Adenocarcinoma Pathological
Cancer in the Northern Territory :
Cancer in the Northern Territory 1991 21: Incidence, mortality and survival Xiaohua Zhang John Condon Karen Dempsey Lindy Garling Acknowledgements The authors are grateful to the many people, who have
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 25 Nov 2018 12:22:24 GMT) CTRI Number Last Modified On 06/07/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Kidney, Bladder and Prostate Neoplasia. David Bingham MD
Kidney, Bladder and Prostate Neoplasia David Bingham MD typical malignant cytology of bladder washings 1 benign 2 malignant typical malignant cytology of bladder washings b Bladder tumor Non invasive papillary
Icd 10 prostate cancer stage 4
Icd 10 prostate cancer stage 4 Search 19-9-2016 City of Hope's prostate cancer program in so. Calif. has pioneered treatments and research that eradicate cancer while minimizing side effects. Our. Augsburg
Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.
Quiz 1 Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios. 1. 62 year old Brazilian female Race 1 Race 2 Spanish/Hispanic Origin 2. 43 year old Asian male born in Japan Race 1
Teratocarcinoma In A Young Boy- An Unusual Presentation
Human Journals Case Report November 2015 Vol.:2, Issue:1 All rights are reserved by Atia Zaka-ur-Rab et al. Teratocarcinoma In A Young Boy- An Unusual Presentation Keywords: Boy, Testicular Mass, Teratocarcinoma
International London Uropathology Conference 2014
Wednesday 18 June 2014 Pre-Conference Registration, Slide Preview & Multiheader Sessions 18.00-21:00: Registration 18.00-21:00: View slide library cases 18:30-19:20: Multiheader Sessions Coronet Room Multiheader
UICC TNM 8 th Edition Errata
UICC TNM 8 th Edition Errata ions are in italics Head and Neck Tumours Pages 20, p27, p34, p38, p41, and p49 ly pn2a Metastasis in a single ipsilateral lymph node, less than 3cm in greatest dimension with
Physician to Physician AJCC 8 th Edition. Head and Neck. Summary of Changes. AJCC Cancer Staging Manual, 7 th Ed. Head and Neck Chapters
Physician to Physician Head and Neck William M. Lydiatt, MD Chair of Surgery Nebraska Methodist Hospital Clinical Professor of Surgery, Creighton University Validating science. Improving patient care.
Cancer in Ireland with estimates for
Cancer in Ireland 1994-2015 with estimates for 2015-2017: Annual Report of the National Cancer Registry 2017 Page ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised
ALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2011-2015) AVERAGE NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 4,557 4,516 9,073 1 2,196 1,984 4,180
GERM-CELL TUMOURS. ESMO Preceptorship on Adolescents and Young Adults with cancer Lugano, May 2018
ESMO Preceptorship on Adolescents and Young Adults with cancer Lugano, 11-12 May 2018 GERM-CELL TUMOURS Giannis Mountzios MSc, PhD Medical Oncology University of Athens School of Medicine Athens, Greece
Cancer of Unknown Primary (CUP)
Cancer of Unknown Primary (CUP) Pathways and Guidelines V1.0 London Cancer September 2013 The following pathways and guidelines document has been compiled by the London Cancer CUP technical subgroup and
2% of all malignancies Male predominance Patients usually more than 60 years old
Benign Bladder Tumors Transitional Cell Papilloma 2-3% Inverted Papilloma Rare Malignant Transitional (Urothelial) Carcinoma 90% Carcinoma In-Situ (By Itself) 5-10% Squamous Cell Carcinoma 3-7% Adenocarcinoma
Case E1. Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour
Case E1 Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour Tumour 1 Upper pole tumour 28mm macro diameter Circumscribed Friable cut surface Tumour 2 Middle pole Part solid
Transitional Cell Papilloma 2-3% Inverted Papilloma Rare
BLADDER TUMORS Benign Transitional Cell Papilloma 2-3% Inverted Papilloma Rare Malignant Transitional (Urothelial) Carcinoma90% Carcinoma In-Situ (By Itself) 5-10% Squamous Cell Carcinoma 3-7% Adenocarcinoma
ALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2012-2016) AVERAGE NUMBER OF DEATHS PER YEAR (2012-2016) Male Female Both sexes Male Female Both sexes 4,607 4,632 9,240 1 2,238 2,036 4,274
Histopathological Study of Lacrimal Gland Tumors
ORIGINAL ARTICLE Pratikkumar B. Desai 1, Ami Shah 2 1 4 th Year Resident, Pathology Department, B.J.Medical College, Civil Hospital, Ahmedabad 2 Associate Professor, M. J. Institute of Ophthalmology, Civil
Cancer of Unknown Primary
Cancer of Unknown Primary Helen Rickards Acute Oncology and Cancer of Unknown Primary CNS 18 th May 2017 Defining CUP Incidence Patient Pathways getting a diagnosis Patient assessment The patient s perspective
Citation for published version (APA): Lutke Holzik, M. F. (2007). Genetic predisposition to testicular cancer s.n.
University of Groningen Genetic predisposition to testicular cancer Lutke Holzik, Martijn Frederik IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
3 cell types in the normal ovary
Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors (neoplasms) 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal
CODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser
CODING STAGE: TNM AND OTHER STAGING SYSTEMS Liesbet Van Eycken Otto Visser OVERVIEW PART I Introduction What is stage? Why stage? History and publications of TNM Classification Clinical and pathologic
Recently, there has been an increasing incidence among women and younger persons
Bladder Tumors Benign Transitional Cell Papilloma 2-3% Inverted Papilloma Rare Malignant Transitional (Urothelial) Carcinoma 90% Carcinoma In-Situ (By Itself) 5-10% Squamous Cell Carcinoma 3-7% Adenocarcinoma
7 Mousa. Obada Zalat. Mohammad Badi
7 Mousa Obada Zalat Mohammad Badi Tumors of the ovaries Last lecture we talked about surface epithelial tumors of the ovaries (the most common type). But there are many other types of tumors of germ cell
Pathology Mystery and Surprise
Pathology Mystery and Surprise Tim Smith, MD Director Anatomic Pathology Medical University of South Carolina Disclosures No conflicts to declare Some problem cases Kidney tumor Scalp tumor Bladder tumor
Reporting of carcinoma of unknown primary tumour (CUP)
Reporting of carcinoma of unknown primary tumour (CUP) Prof John Schofield Kent Oncology Centre with grateful thanks to Dr Karin Oien University of Glasgow Royal College of Pathologists Cancer datasets
Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.
Male genital tract tumors Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. adenocarcinoma Prostate Cancer most common male cancer in western countries more detected in
Tinh hoàn
Tinh hoàn Tinh hoàn Tinh hoàn Tiền liệt tuyến Tiền liệt tuyến Mào tinh hoàn Mào tinh hoàn Túi tinh Túi tinh Túi tinh Túi tinh So-called cystadenoma of seminal vesicle. Gross appearance of granulomatous
Extratesticular Extension of Germ Cell Tumors Preferentially Occurs at the Hilum
Anatomic Pathology / EXTRATESTICULAR EXTENSION OF GERM CELL TUMORS Extratesticular Extension of Germ Cell Tumors Preferentially Occurs at the Hilum Sarah M. Dry, MD, and Andrew A. Renshaw, MD Key Words: